Coxsackievirus B3 protease 3C: expression, purification, crystallization and preliminary structural insights
Stavroula Fili1, Alexandros Valmas1, Magdalini Christopoulou1
1Section of Genetics, Cell Biology and Development, Department of Biology, University of Patras, University Campus, 26500 Patras, Greece.
Acta Crystallographica. Section F, Structural Biology Communications
|December 6, 2016
Summary
Researchers crystallized coxsackievirus B3 protease 3C, a key enzyme in viral replication and myocarditis. X-ray powder diffraction identified a monoclinic polymorph, aiding structural determination.
Area of Science:
- Structural Biology
- Virology
- Crystallography
Background:
- Viral proteases are essential enzymes for viral replication and assembly.
- Coxsackievirus B3 protease 3C is implicated in viral myocarditis.
- Understanding viral protease structure is crucial for antiviral drug development.
Purpose of the Study:
- To express, purify, crystallize, and perform preliminary X-ray diffraction analysis of coxsackievirus B3 protease 3C.
- To identify crystalline forms suitable for X-ray powder diffraction (XRPD).
- To lay the groundwork for complete structural determination of the protease.
Main Methods:
- Protein expression and purification of coxsackievirus B3 protease 3C.
- Crystallization using PEG 4000, Tris-HCl, and MgCl2 under specific pH conditions.
- X-ray powder diffraction (XRPD) for polymorph identification and symmetry determination.
Main Results:
- Polycrystalline protein precipitates were successfully produced.
- XRPD analysis identified a monoclinic polymorph with space group C2.
- Unit-cell parameters were determined: a = 77.9, b = 65.7, c = 40.6 Å, β = 115.9°.
Conclusions:
- The study presents the first step towards the complete structural determination of coxsackievirus B3 protease 3C via XRPD.
- The findings demonstrate the utility of XRPD for characterizing viral protease polymorphs.
- This structural information is vital for understanding viral pathogenesis and designing targeted therapies.
